Author

Robert B. Mboizi

Observed names: Mboizi, Robert, Robert Mboizi

Institutions: University of Antwerp, MUJHU Research Collaboration, Makerere University

Observed institutions: Johns Hopkins University, University of Antwerp, University of Malawi, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Mulago Hospital, London School of Hygiene & Tropical Medicine, MRC Unit the Gambia, MUJHU Research Collaboration, Makerere University, Medical Research Council

OpenAlex ID: A5072063302

Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda

2021 · Jessica Florence Burt, Joseph Ouma, et al. · BMJ Global Health · 184

PDF

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

2016 · Robert S Heyderman, Shabir A Madhi, et al. · The Lancet Infectious Diseases · 133

PDF

Vaccine value profile for Klebsiella pneumoniae

2024 · Ziyaad Dangor, Nicole Benson, et al. · Vaccine · 67

Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial

2020 · Willy Ssengooba, Jean de Dieu Iragena, et al. · Journal of Clinical Microbiology · 35

The immunogenicity and safety of Group B Streptococcal maternal vaccines: A systematic review

2023 · Aline U. Bjerkhaug, Shouwmika Ramalingham, et al. · Vaccine · 22

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial

2017 · Olubukola T. Idoko, Robert B. Mboizi, et al. · Vaccine · 15

Acceptance of multiple injectable vaccines in a single immunization visit in The Gambia pre and post introduction of inactivated polio vaccine

2016 · Olubukola T. Idoko, Lee M. Hampton, et al. · Vaccine · 12

PDF

Recall and decay of consent information among parents of infants participating in a randomized controlled clinical trial using an audio-visual tool in The Gambia

2017 · Robert B. Mboizi, Muhammed O. Afolabi, et al. · Human Vaccines & Immunotherapeutics · 11

PDF

Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial

2024 · Chishala Chabala, Eric Wobudeya, et al. · Clinical Infectious Diseases · 7

PDF

Maternal vaccination to prevent neonatal infections and combat antimicrobial resistance

2025 · Eva P. Galiza, Eve Nakebembe, et al. · Seminars in Fetal and Neonatal Medicine · 4

Sociodemographic Factors Associated With Established and Novel Antenatal Vaccination Uptake in a Cohort of Pregnant Women in Uganda

2025 · Sarah Sturrock, Hannah Davies, et al. · The Pediatric Infectious Disease Journal · 3

COVID-19 disease and vaccination in pregnancy: understanding knowledge, perceptions and experiences among pregnant women and community leaders in Uganda

2023 · Phiona Nalubega, Ritah Namugumya, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 3

PDF

Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial

2026 · Robert Mboizi, Musa Sekikubo, et al. · The Lancet Infectious Diseases · 2

“Now that the baby is out, I can be vaccinated”: a qualitative study on COVID-19 vaccine hesitancy in pregnant women in Kilifi, Kenya

2026 · Angela Koech, Onesmus Wanje, et al. · Frontiers in Public Health · 2

PDF

Protocol for a pregnancy registry of maternal and infant outcomes in Uganda –The PREPARE Study

2022 · Hannah Davies, Simon Afrika, et al. · Wellcome Open Research · 2

Baseline adverse birth outcomes in a prospective pregnancy cohort in Uganda: Evidence to inform maternal vaccine readiness

2026 · Hannah G. Davies, Gordon Rukundo, et al. · Vaccine · 1

Updating the evidence on brighton collaboration's GAIA maternal immunisation case definitions: a systematic review of performance and implementation challenges

2026 · Robert Mboizi, Kirsten Maertens, et al. · Vaccine

Serological thresholds of risk reduction for infant group B streptococcus disease

2026 · Liberty Cantrell, Kostas Karampatsas, et al. · medRxiv

SARS-CoV-2 seroprevalence among pregnant women during the first three waves of the COVID-19 pandemic in southern Mozambique

2026 · Esperança Sevene, Sónia Maculuve, et al. · BMC Pregnancy and Childbirth

Mapping key determinants of maternal vaccine uptake in Uganda using the 6As taxonomy. A qualitative study with key stakeholders.

2026 · Khamisi Musanje, Ritah Namugumya, et al.

Corrigendum to “The immunogenicity and safety of Group B Streptococcal maternal vaccines: A systematic review” [Vaccine 42 (2024) 84–98]

2025 · Aline U. Bjerkhaug, Shouwmika Ramalingham, et al. · Vaccine

Works count: 23

Citation count: 503

H-index: 8

I10-index: 8